Novo Nordisk B A/S

NOVO-B 
(NasdaqOMXC) 
 

To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

dkk 266.50
Updated 16:20:00
ISIN: DK0060534915
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 3,075,473
High DKK 268.30
Low DKK 264.40
Open DKK 266.50
 
Prev close DKK 266.50
# of shares 2,112.56M
Market cap 562,998M DKK
Intraday

Market closed
Novo Nordisk B A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  266.50 1.9% Stock price increasing -0.2% Stock price decreasing 3.7% Stock price increasing 14.1% Stock price increasing 39.2% Stock price increasing
Key Figures (m)
Turnover
EBIT
Net Profit
Equity
Balance
2013
83,572
0
25,184
42,569
70,337
2012
78,026
28,837
21,432
40,632
65,669
2011
66,346
22,056
17,097
37,448
64,698
2010
60,776
18,302
14,403
36,965
61,402
2009
51,078
14,839
10,768
35,734
54,742
2008
45,553
12,571
9,645
32,979
50,603
2007
41,831
10,009
8,522
32,182
47,731

Company profile

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Targets for: Novo Nordisk B A/S

 
Analyst
Target
Date
Novo/Exane: Indleder dækning med
BNP Paribas
270 ingen ændring
08:52
Novo/SEB: Hæver kursmål til 350 kr. fra 260 kr.
SEB Enskilda
350 op
20/05/14
Novo/Jefferies: Hæver kursmål til 260 kr.
Jefferies
260 op
19/03/14
Novo/Exane: Løfter kursmål til 220 kr. fra 176 kr.
BNP Paribas
220 op
17/03/14
Novo/Barclays: Løfter kursmålet til 275
Barclays
275 op
10/03/14
Novo/S&P: Hæver kursmål til 280 kr
S&P Equity Research
280 op
07/03/14
Novo/Natixis: Løfter kursmål til 285 kr. fra 240 kr.
Natixis
285 op
26/02/14
Novo/UBS: Kursmålet løftes med 30 kr. til 260 kr.
UBS
260 op
14/02/14
Novo/Helvea: Hæver kursmål med 20 kr. til 250 kr.
Helvea
250 op
31/01/14
Novo/UBS: Løfter kursmål til 230 kr. fra 208 kr.
UBS
230 op
10/01/14
Euroinvestor around the globe: Euroinvestor.dk | Euroinvestor.se | Euroinvestor.no | Euroinvestor.fr | Forexinvestor.com| Wisselkoersen.nl | Valuta.se | Valutaveksel.no | Divisas.es | Valute.it
Copyright Euroinvestor A/S 2014   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 November 2014 20:35:42
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20141125.1 - EUROWEB7 - 2014-11-25 21:35:42 - 2014-11-25 20:35:42 - 1000 - Website: OKAY